OptimizeRx Corp (NAS:OPRX)
$ 10.54 -0.27 (-2.5%) Market Cap: 191.66 Mil Enterprise Value: 219.54 Mil PE Ratio: 0 PB Ratio: 1.51 GF Score: 77/100

Q1 2021 OPTIMIZERx Corp Earnings Call Transcript

May 06, 2021 / 08:30PM GMT
Release Date Price: $47.95 (-4.39%)
Operator

Good afternoon. Thank you for joining us today to discuss OptimizeRx Corporation's First Quarter Ended March 31, 2021. Speaking on the call today is OptimizeRx's Chief Executive Officer, William Febbo; and the company's Chief Financial Officer, Doug Baker. Miriam Paramore, the company's Chief Strategy Officer and Chief Commercial Officer; Stephen Silvestro will be present for the Q&A. Following their remarks, they will open the call for questions.

Before we conclude today's call, I'll provide some important cautions regarding the forward-looking statements made by management during today's call. I'd like to remind everyone that today's call is being recorded and will be made available for replay via webcast only and instructions in today's press release in the Investors section of the company's website.

Now I'll turn the call over to OptimizeRx CEO Will Febbo. Sir, please go ahead.

William J. Febbo
OptimizeRx Corporation - CEO & Director

Thank you, Ron. Good afternoon, everyone, and thanks for joining us on the call today. I am

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot